Internal Medicine, Hematology & Oncology · Steubenville, OH
NPI
1376715284
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3204 Johnson Rd, Teramana Cancer Center
Steubenville, OH, 43952
Phone (740) 266-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,267 services
Medicare patients, 2024
442
Average age 74
Drug cost, 2024
$2.1M
1,148 prescriptions
Company payments, 2025
$1,054
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aaron Provenzano was code 99214 (office e&m - established), 413 times for 259 patients. In total Aaron Provenzano billed 1,267 services in 14 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 413 | 259 | $68.25 | $28K |
| 99215 Office E&M - Established | Facility | 278 | 101 | $104.38 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 209 | 161 | $12.46 | $2,604 |
| 99213 Office E&M - Established | Facility | 112 | 99 | $45.11 | $5,052 |
| 99232 Hospital E&M - Subsequent | Facility | 88 | 42 | $59.53 | $5,239 |
| 99204 Office E&M - New | Facility | 51 | 51 | $99.80 | $5,090 |
| 99222 Hospital E&M - Initial | Facility | 48 | 42 | $98.84 | $4,744 |
| 99205 Office E&M - New | Facility | 38 | 38 | $137.21 | $5,214 |
| 99223 Hospital E&M - Initial | Facility | 13 | 12 | $131.14 | $1,705 |
By year: 2022 $79K for 962 services; 2023 $86K for 1,033 services; 2024 $88K for 1,267 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aaron Provenzano prescribed most often to Medicare patients was Anastrozole, with 119 prescriptions and refills. In total Aaron Provenzano wrote 1,148 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 119 | 270 | 41 | $1,333 |
| Eliquis Apixaban | 117 | 198 | 35 | $110K |
| Ondansetron Hcl Generic | 70 | 70 | 47 | $2,069 |
| Prednisone Generic | 67 | 72 | 31 | $216 |
| Oxycodone Hcl Generic | 66 | 66 | 42 | $1,547 |
| Exemestane Generic | 45 | 77 | Under 11 | $5,940 |
| Xarelto Rivaroxaban | 35 | 45 | Under 11 | $25K |
| Letrozole Generic | 27 | 61 | 11 | $756 |
| Abiraterone Acetate Generic | 23 | 23 | Under 11 | $114K |
| Calquence Acalabrutinib Maleate | 23 | 23 | Under 11 | $261K |
| Everolimus Generic | 22 | 22 | Under 11 | $95K |
| Ibrance Palbociclib | 21 | 21 | Under 11 | $217K |
| Prochlorperazine Maleate Generic | 20 | 20 | 12 | $271 |
| Xtandi Enzalutamide | 20 | 20 | Under 11 | $281K |
| Levofloxacin Generic | 18 | 18 | 12 | $65.23 |
Brand drugs: 309 claims; generic drugs: 839 claims; opioid claims: 113.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aaron Provenzano $1,054 ($1,054 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $186.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $186 |
| Galvanize Therapeutics, Inc | 1 | $164 |
| Tempus AI, Inc TEM | 2 | $111 |
| Seagen Inc. PFE | 1 | $99.99 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $74.11 |
| Astellas Pharma US Inc 4503.T | 2 | $61.35 |
| Exelixis Inc. EXEL | 2 | $52.79 |
| Incyte Corporation INCY | 2 | $49.45 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $49.16 |
| Pfizer Inc. PFE | 3 | $31.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.